Literature DB >> 32052171

Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1.

Giorgio Brembilla1, Paolo Dell'Oglio2, Armando Stabile2, Anna Damascelli3, Lisa Brunetti3, Silvia Ravelli3, Giulia Cristel3, Elena Schiani3, Elena Venturini3, Daniele Grippaldi3, Vincenzo Mendola4, Paola Maria Vittoria Rancoita5, Antonio Esposito3, Alberto Briganti2, Francesco Montorsi2, Alessandro Del Maschio3, Francesco De Cobelli3.   

Abstract

OBJECTIVES: To evaluate the agreement among readers with different expertise in detecting suspicious lesions at prostate multiparametric MRI using Prostate Imaging Reporting and Data System (PI-RADS) version 2.1.
METHODS: We evaluated 200 consecutive biopsy-naïve or previously negative biopsy men who underwent MRI for clinically suspected prostate cancer (PCa) between May and September 2017. Of them, 132 patients underwent prostate biopsy. Seven radiologists (four dedicated uro-radiologists and three non-dedicated abdominal radiologists) reviewed and scored all MRI examinations according to PI-RADS v2.1. Agreement on index lesion detection was evaluated with Conger's k coefficient, agreement coefficient 1 (AC1), percentage of agreement (PA), and indexes of specific positive and negative agreement. Clinical and radiological features that may influence variability were evaluated.
RESULTS: Agreement in index lesion detection among all readers was substantial (AC1 0.738; 95% CI 0.695-0.782); dedicated radiologists showed higher agreement compared with non-dedicated readers. Clinical and radiological parameters that positively influenced agreement were PSA density ≥ 0.15 ng/mL/cc, pre-MRI high risk for PCa, positivity threshold of PI-RADS score 4 + 5, PZ lesions, homogeneous signal intensity of the PZ, and subjectively easy interpretation of MRI. Positive specific agreement was significantly higher among dedicated readers, up to 93.4% (95% CI 90.7-95.4) in patients harboring csPCa. Agreement on absence of lesions was excellent for both dedicated and non-dedicated readers (respectively 85.1% [95% CI 78.4-92.3] and 82.0% [95% CI 77.2-90.1]).
CONCLUSIONS: Agreement on index lesion detection among radiologists of various experiences is substantial to excellent using PI-RADS v2.1. Concordance on absence of lesions is excellent across readers' experience. KEY POINTS: • Agreement on index lesion detection among radiologists of various experiences is substantial to excellent using PI-RADS v2.1. • Concordance between experienced readers is higher than between less-experienced readers. • Concordance on absence of lesions is excellent across readers' experience.

Entities:  

Keywords:  Inter-observer variability; Magnetic resonance imaging; Prostate cancer

Mesh:

Year:  2020        PMID: 32052171     DOI: 10.1007/s00330-019-06654-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

1.  MRI as a screening tool for prostate cancer: current evidence and future challenges.

Authors:  Christoph Würnschimmel; Thenappan Chandrasekar; Luisa Hahn; Tarik Esen; Shahrokh F Shariat; Derya Tilki
Journal:  World J Urol       Date:  2022-02-28       Impact factor: 4.226

2.  Quantitative Analysis of Diffusion Weighted Imaging May Improve Risk Stratification of Prostatic Transition Zone Lesions.

Authors:  Hannes Engel; Benedict Oerther; Marco Reisert; Elias Kellner; August Sigle; Christian Gratzke; Peter Bronsert; Tobias Krauss; Fabian Bamberg; Matthias Benndorf
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

3.  68Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement.

Authors:  Daniela A Ferraro; Andreas M Hötker; Olivio F Donati; Irene A Burger; Anton S Becker; Iliana Mebert; Riccardo Laudicella; Anka Baltensperger; Niels J Rupp; Jan H Rueschoff; Julian Müller; Ashkan Mortezavi; Marcelo T Sapienza; Daniel Eberli
Journal:  Eur J Hybrid Imaging       Date:  2022-07-18

4.  Promoting the use of the PRECISE score for prostate MRI during active surveillance: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship.

Authors:  Francesco Giganti; Laurene Aupin; Camille Thoumin; Ingrid Faouzi; Hippolyte Monnier; Matthieu Fontaine; Alexandre Navidi; Paul-Gydéon Ritvo; Valentin Ong; Cecile Chung; Imen Bibi; Raphaële Lehrer; Nicolas Hermieu; Eric Barret; Alessandro Ambrosi; Veeru Kasivisvanathan; Mark Emberton; Clare Allen; Alex Kirkham; Caroline M Moore; Raphaële Renard-Penna
Journal:  Insights Imaging       Date:  2022-07-07

5.  Comparison of prostate imaging reporting and data system v2.1 and 2 in transition and peripheral zones: evaluation of interreader agreement and diagnostic performance in detecting clinically significant prostate cancer.

Authors:  Yasuyo Urase; Yoshiko Ueno; Tsutomu Tamada; Keitaro Sofue; Satoru Takahashi; Nobuyuki Hinata; Kenichi Harada; Masato Fujisawa; Takamichi Murakami
Journal:  Br J Radiol       Date:  2021-07-08       Impact factor: 3.039

6.  Comparison of diagnostic performance and inter-reader agreement between PI-RADS v2.1 and PI-RADS v2: systematic review and meta-analysis.

Authors:  Chau Hung Lee; Balamurugan Vellayappan; Cher Heng Tan
Journal:  Br J Radiol       Date:  2021-09-14       Impact factor: 3.039

7.  Systematic sampling during MRI-US fusion prostate biopsy can overcome errors of targeting-prospective single center experience after 300 cases in first biopsy setting.

Authors:  Emanuel Cata; Iulia Andras; Matteo Ferro; Pierre Kadula; Daniel Leucuta; Gennaro Musi; Deliu-Victor Matei; Ottavio De Cobelli; Attila Tamas-Szora; Cosmin Caraiani; Andrei Lebovici; Flavia Epure; Maria Bungardean; Radu-Tudor Coman; Nicolae Crisan
Journal:  Transl Androl Urol       Date:  2020-12

8.  The Role of PSA Density among PI-RADS v2.1 Categories to Avoid an Unnecessary Transition Zone Biopsy in Patients with PSA 4-20 ng/mL.

Authors:  Zhi-Bing Wang; Chao-Gang Wei; Yue-Yue Zhang; Peng Pan; Guang-Cheng Dai; Jian Tu; Jun-Kang Shen
Journal:  Biomed Res Int       Date:  2021-10-11       Impact factor: 3.411

9.  Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer.

Authors:  Madhuri Monique Rudolph; Alexander Daniel Jacques Baur; Hannes Cash; Matthias Haas; Samy Mahjoub; Alexander Hartenstein; Charlie Alexander Hamm; Nick Lasse Beetz; Frank Konietschke; Bernd Hamm; Patrick Asbach; Tobias Penzkofer
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

10.  Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial.

Authors:  Francesco Giganti; Eoin Dinneen; Veeru Kasivisvanathan; Aiman Haider; Alex Freeman; Alex Kirkham; Shonit Punwani; Mark Emberton; Greg Shaw; Caroline M Moore; Clare Allen
Journal:  Eur Radiol       Date:  2021-07-29       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.